# Rock Maple Ventures

> Rock Maple Ventures is a VC fund in Boston backing Biotechnology and Security. See 11 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Boston, United States
- Total investments: 11
- Last investment: Mar 2026
- Lead investor: 36%
- Last updated: Aug 2026
- Website: http://www.rockmapleventures.com/

Rock Maple Ventures is an early stage venture capital firm founded in 2001 which is based in Boston, Massachusetts with an additional office in New York, NY. Rock Maple's primary area of focus is investments in early stage businesses in the information technology and medical technology industries. Geographically, the firm seeks to invest incompanies based in the United States.Rock Maple typically invests between $1 and $3 million to start and up to $5 million over the life of a portfolio company. The firm generally seeks to lead or co-lead investments.

## Contacts

5 contacts available for Rock Maple Ventures. Shizune tracks 2 team members at Rock Maple Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/rock-maple-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Pre-Seed | $1M–$3M |
| Series C | $5M–$26M |
| Series D | $5M–$10M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 27% |
| Security | 2 | 18% |
| Life Science | 2 | 18% |
| Medical | 1 | 9% |
| Genetics | 1 | 9% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 4 | 36% |
| Series D | 2 | 18% |
| Pre-Seed | 1 | 9% |
| Funding Round | 1 | 9% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 5 | 45% |
| Georgia | 1 | 9% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Freelove | Founder & Managing Partner | 0 | https://shizune.co/investors/profile/david-freelove |
| Tatjana Vanjak | Team Member | 0 | https://shizune.co/investors/profile/tatjana-vanjak |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| JewelMusic | JewelMusic is your intelligent copilot that helps artists craft perfect lyrics that match their music's rhythm and emotion. Work alongside AI to enhance your creative process while maintaining complete artistic control. | $3M | Pre-Seed | Mar 18, 2026 |  |
| JewelMusic | JewelMusic is your intelligent copilot that helps artists craft perfect lyrics that match their music's rhythm and emotion. Work alongside AI to enhance your creative process while maintaining complete artistic control. | $1M | Pre-Seed | Jun 01, 2025 |  |
| LeadExplorer | The e-commerce marketing platform for growing direct-to-consumer brands. Only AdRoll gives you the power to connect, automate, and measure the whole customer journey, across the web. | $2.1M | Series A | Oct 20, 2024 |  |
| Seahorse Bioscience | Seahorse Bioscience provides analytical instruments, biomanufacturing systems and consumable labware products for biological research and drug discovery. The company's customers include scientists at academic institutions, pharmaceutical and biotech organizations, as well as OEM manufacturers of assay kits and lab instruments suppliers. | $5M | Series D | Mar 08, 2010 |  |
| Memento | Memento, designs and delivers enterprise fraud and compliance solutions for proactive monitoring, detection, real-time alerts, and investigation to credit unions and community banks in North America and Europe. It offers Security 4.0, an enterprise fraud and compliance platform that combines data management, fraud analytics, and case managementcapabilities to address technological issues, as well as enables banks or credit unions to address damaging fraud and compliance schemes. The company also provides solutions to monitor new account frauds across various channels, products, transaction types, and accounts; insider issue solutions to monitor transaction data, general ledger, and other data sources; and deposit account fraud solutions to protect deposit accounts. In addition, it offers enterprise fraud solutions for smaller banks or credit unions; Memento Security - Check Fraud, a check fraud prevention solution for banks; and solutions that address regulatory requirements, as well as enable organizations to detect, prevent, mitigate, and document identity theft and other issues to protect customers against identity theft. The company was founded in 2002 and is based in Concord, Massachusetts with additional offices in New York, Los Angeles, Milan, London, and Washington, D.C. | $10M | Series D | Nov 05, 2008 |  |
| Memento | Memento, designs and delivers enterprise fraud and compliance solutions for proactive monitoring, detection, real-time alerts, and investigation to credit unions and community banks in North America and Europe. It offers Security 4.0, an enterprise fraud and compliance platform that combines data management, fraud analytics, and case managementcapabilities to address technological issues, as well as enables banks or credit unions to address damaging fraud and compliance schemes. The company also provides solutions to monitor new account frauds across various channels, products, transaction types, and accounts; insider issue solutions to monitor transaction data, general ledger, and other data sources; and deposit account fraud solutions to protect deposit accounts. In addition, it offers enterprise fraud solutions for smaller banks or credit unions; Memento Security - Check Fraud, a check fraud prevention solution for banks; and solutions that address regulatory requirements, as well as enable organizations to detect, prevent, mitigate, and document identity theft and other issues to protect customers against identity theft. The company was founded in 2002 and is based in Concord, Massachusetts with additional offices in New York, Los Angeles, Milan, London, and Washington, D.C. | $7.5M | Series C | May 09, 2007 |  |
| Courtagen Life Sciences | Courtagen Life Sciences is a biotech company that provides proteomic and genomic products and services to the life sciences industry. The company delivers tools that enable researchers and clinicians to make better decisions regarding drug development and patient care. It was founded in 1999 and headquartered in Woburn, Massachusetts. | $7.6M |  | Feb 01, 2006 |  |
| Seahorse Bioscience | Seahorse Bioscience provides analytical instruments, biomanufacturing systems and consumable labware products for biological research and drug discovery. The company's customers include scientists at academic institutions, pharmaceutical and biotech organizations, as well as OEM manufacturers of assay kits and lab instruments suppliers. | $11.5M | Series C | Feb 01, 2005 |  |
| Courtagen Life Sciences | Courtagen Life Sciences is a biotech company that provides proteomic and genomic products and services to the life sciences industry. The company delivers tools that enable researchers and clinicians to make better decisions regarding drug development and patient care. It was founded in 1999 and headquartered in Woburn, Massachusetts. | $6.6M |  | Sep 23, 2004 |  |
| Morphotek | Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continuesto develop additional antibody products using its proprietary technologies.Post-graduate research executed by Morphotek’s President and CEO, Dr. Nicholas Nicolaides, during his studies at Johns Hopkins Medical School was the basis for the company’s inception. It was there that Dr. Nicolaides co-invented the company's legacy technology called morphogenics. Along with the honed applications for applying morphogenics for product development refined by the company’s other co-founders, Dr. Philip Sass and Dr. Luigi Grasso, morphogenics has taken Morphotek an incredible distance in the advancement of novel pharmaceutical products and targets. | $26M | Series C | Feb 20, 2004 |  |

10 of 11 investments shown.

## Co-investors
- [Oxford Bioscience Partners](https://shizune.co/investors/profile/oxford-bioscience-partners) — VC Fund, 3 deals together
- [.406 Ventures](https://shizune.co/investors/profile/406-ventures) — VC Fund, 2 deals together
- [Bain Capital Ventures](https://shizune.co/investors/profile/bain-capital-ventures) — VC Fund, 2 deals together
- [Commonwealth Capital Ventures](https://shizune.co/investors/profile/commonwealth-capital-ventures) — VC Fund, 2 deals together
- [Flagship Pioneering](https://shizune.co/investors/profile/flagship-ventures) — VC Fund, 2 deals together
- [AppVested](https://shizune.co/investors/profile/appvested) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

### Similar country
- [European Bank for Reconstruction and Development](https://shizune.co/investors/profile/european-bank-for-reconstruction-and-development-ebrd) — VC Fund
- [Tether](https://shizune.co/investors/profile/tether-50cc) — VC Fund
- [AppVested](https://shizune.co/investors/profile/appvested) — VC Fund

## Featured in investor lists
- [All Investors in Georgia](https://shizune.co/investors/investors-georgia)
- [All VC Funds in Georgia](https://shizune.co/investors/vc-funds-georgia)

## FAQ

### What does Rock Maple Ventures invest in?

Rock Maple Ventures invests primarily in Biotechnology, Security and Life Science startups, most often at Series C and Series D stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Rock Maple Ventures's check size?

Rock Maple Ventures typically joins rounds of $1M–$3M at Pre-Seed, $5M–$26M at Series C and $5M–$10M at Series D. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Rock Maple Ventures participates in.

### How do I contact Rock Maple Ventures?

Public channels for Rock Maple Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Rock Maple Ventures?

The team at Rock Maple Ventures includes David Freelove (Founder & Managing Partner) and Tatjana Vanjak (Team Member). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co